J.Safra Asset Management Corp Legend Biotech Corp Transaction History
J.Safra Asset Management Corp
- $1.2 Billion
- Q4 2024
A detailed history of J.Safra Asset Management Corp transactions in Legend Biotech Corp stock. As of the latest transaction made, J.Safra Asset Management Corp holds 28 shares of LEGN stock, worth $918. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28
Previous 28
-0.0%
Holding current value
$918
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding LEGN
# of Institutions
232Shares Held
84.2MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$246 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$223 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$196 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$188 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$187 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.49B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...